ENZALUTAMIDE ENHANCES GLYCOLYSIS IN CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Liu, Wang
Li, Jean
Artigues, Antonio
Yao, Si
Li, Benyi
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD44-12
引用
收藏
页码：E741 / E741
页数：1
相关论文
共 50 条
  • [41] Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
    Schrader, Andres Jan
    Boegemann, Martin
    Ohlmann, Carsten-H.
    Schnoeller, Thomas J.
    Krabbe, Laura-Maria
    Hajili, Turkan
    Jentzmik, Florian
    Stoeckle, Michael
    Schrader, Mark
    Herrmann, Edwin
    Cronauer, Marcus V.
    EUROPEAN UROLOGY, 2014, 65 (01) : 30 - 36
  • [42] Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate Cancer
    Yamasaki, Mutsushi
    Yuasa, Takeshi
    Yamamoto, Shinya
    Hayashi, Tatsuro
    Ogawa, Masahiro
    Sakura, Mizuaki
    Masuda, Hitoshi
    Fukui, Iwao
    Yonese, Junji
    ANTICANCER RESEARCH, 2016, 36 (01) : 361 - 365
  • [43] Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 31 - 31
  • [44] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Schmid, Sebastian Christoph
    Geith, Alexander
    Boeker, Alena
    Tauber, Robert
    Seitz, Anna Katharina
    Kuczyk, Markus
    von Klot, Christoph
    Gschwend, Juergen Erich
    Merseburger, Axel Stuart
    Retz, Margitta
    ADVANCES IN THERAPY, 2014, 31 (02) : 234 - 241
  • [45] Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it
    Wang, Yuanyuan
    Chen, Jiyuan
    Wu, Zhengjie
    Ding, Weihong
    Gao, Shen
    Gao, Yuan
    Xu, Chuanliang
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 239 - 261
  • [46] Identifying enzalutamide resistance mechanisms in men with castration-resistant prostate cancer.
    Alumkal, Joshi J.
    Heiser, Laura
    Beer, Tomasz M.
    Small, Eric Jay
    Baertsch, Robert
    Stuart, Josh
    King, Carly
    Korkola, James
    Cetnar, Jeremy
    Graff, Julie Nicole
    Thomas, George
    Ryan, Christopher W.
    Toschi, Alexandria
    Youngren, Jack
    Tucker, Erin
    Ellers, Kristi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Initial evaluation of the clinical efficacy and safety of enzalutamide in castration-resistant prostate cancer
    Miura, Noriyoshi
    Kakuta, Toshio
    Noda, Terutaka
    Asai, Seiji
    Fukumoto, Tetsuya
    Yanagihara, Yutaka
    Miyauchi, Yuki
    Kikugawa, Tadahiko
    Tanji, Nozomu
    Yokoyama, Masayoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 145 - 145
  • [48] Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer
    Mayao Luo
    Yifan Zhang
    Zhuofan Xu
    Chenwei Wu
    Yuedian Ye
    Rui Liu
    Shidong Lv
    Qiang Wei
    Cell Death Discovery, 8
  • [49] In vivo efficacy of PSMA ADC in combination with enzalutamide in castration-resistant prostate cancer
    DiPippo, Vincent A.
    Nguyen, Holly M.
    Brown, Lisha G.
    Olson, William C.
    Vessella, Robert L.
    Corey, Eva
    CANCER RESEARCH, 2015, 75
  • [50] Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer
    Bagguley, Dominic
    Ong, Sean
    Lawrentschuk, Nathan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2021, 79 (02) : 320 - 321
12345